Clinical trial
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
NCT03065192 · Neurocrine Biosciences, Industry · Completed
Key facts
| NCT number | NCT03065192 |
|---|---|
| Title | Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease |
| Official title | An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa |
| Lead sponsor | Neurocrine Biosciences, Industry |
| Collaborators | Voyager Therapeutics Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease, Brain Diseases, Central Nervous System Diseases, Movement Disorders, Nervous System Diseases, Neurodegenerative Diseases, Parkinsonian Disorders |
| Intervention type | Drug |
| Interventions | VY-AADC01 |
| Enrollment | 16 |
| Start date | May 11, 2017 |
| Primary completion | Aug 10, 2021 |
| Completion | Aug 10, 2021 |
| First posted | Feb 27, 2017 |
| Last update posted | Mar 21, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: